Literature DB >> 22610096

Raf kinase inhibitor protein (RKIP) dimer formation controls its target switch from Raf1 to G protein-coupled receptor kinase (GRK) 2.

Katharina Deiss1, Caroline Kisker, Martin J Lohse, Kristina Lorenz.   

Abstract

Proteins controlling cellular networks have evolved distinct mechanisms to ensure specificity in protein-protein interactions. Raf kinase inhibitor protein (RKIP) is a multifaceted kinase modulator, but it is not well understood how this small protein (21 kDa) can coordinate its diverse signaling functions. Raf1 and G protein-coupled receptor kinase (GRK) 2 are direct interaction partners of RKIP and thus provide the possibility to untangle the mechanism of its target specificity. Here, we identify RKIP dimer formation as an important mechanistic feature in the target switch from Raf1 to GRK2. Co-immunoprecipitation and cross-linking experiments revealed RKIP dimerization upon phosphorylation of RKIP at serine 153 utilizing purified proteins as well as in cells overexpressing RKIP. A functional phosphomimetic RKIP mutant had a high propensity for dimerization and reproduced the switch from Raf1 to GRK2. RKIP dimerization and GRK2 binding, but not Raf1 interaction, were prevented by a peptide comprising amino acids 127-146 of RKIP, which suggests that this region is critical for dimer formation. Furthermore, a dimeric RKIP mutant displayed a higher affinity to GRK2, but a lower affinity to Raf1. Functional analyses of phosphomimetic as well as dimeric RKIP demonstrated that enhanced dimerization of RKIP translates into decreased Raf1 and increased GRK2 inhibition. The detection of RKIP dimers in a complex with GRK2 in murine hearts implies their physiological relevance. These findings represent a novel mechanistic feature how RKIP can discriminate between its different interaction partners and thus advances our understanding how specific inhibition of kinases can be achieved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22610096      PMCID: PMC3390617          DOI: 10.1074/jbc.M112.363812

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Structural characterisation and functional significance of transient protein-protein interactions.

Authors:  Irene M A Nooren; Janet M Thornton
Journal:  J Mol Biol       Date:  2003-01-31       Impact factor: 5.469

Review 2.  Seven-transmembrane receptors.

Authors:  Kristen L Pierce; Richard T Premont; Robert J Lefkowitz
Journal:  Nat Rev Mol Cell Biol       Date:  2002-09       Impact factor: 94.444

3.  Mechanisms of protein oligomerization, the critical role of insertions and deletions in maintaining different oligomeric states.

Authors:  Kosuke Hashimoto; Anna R Panchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-03       Impact factor: 11.205

4.  Human phosphatidylethanolamine-binding protein facilitates heterotrimeric G protein-dependent signaling.

Authors:  T Kroslak; T Koch; E Kahl; V Höllt
Journal:  J Biol Chem       Date:  2001-08-20       Impact factor: 5.157

5.  Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Authors:  K C Yeung; D W Rose; A S Dhillon; D Yaros; M Gustafsson; D Chatterjee; B McFerran; J Wyche; W Kolch; J M Sedivy
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

Review 6.  GRK2 as a novel gene therapy target in heart failure.

Authors:  Giuseppe Rengo; Anastasios Lymperopoulos; Dario Leosco; Walter J Koch
Journal:  J Mol Cell Cardiol       Date:  2010-08-25       Impact factor: 5.000

7.  Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β.

Authors:  Fahd Al-Mulla; Milad S Bitar; May Al-Maghrebi; Abdulla I Behbehani; Waleed Al-Ali; Oliver Rath; Brendan Doyle; Kit Yee Tan; Andrew Pitt; Walter Kolch
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

8.  Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells.

Authors:  Julian Hellmann; Hans Rommelspacher; Eckhard Mühlbauer; Catrin Wernicke
Journal:  Dev Neurosci       Date:  2009-12-03       Impact factor: 2.984

9.  Analysis of monomeric and dimeric phosphorylated forms of protein kinase R.

Authors:  Eric Anderson; Christine Quartararo; Raymond S Brown; Yu Shi; Xudong Yao; James L Cole
Journal:  Biochemistry       Date:  2010-02-16       Impact factor: 3.162

10.  Characterization of the Raf kinase inhibitory protein (RKIP) binding pocket: NMR-based screening identifies small-molecule ligands.

Authors:  Anne N Shemon; Gary L Heil; Alexey E Granovsky; Mathew M Clark; Dan McElheny; Alexander Chimon; Marsha R Rosner; Shohei Koide
Journal:  PLoS One       Date:  2010-05-05       Impact factor: 3.240

View more
  30 in total

1.  SSPaQ: A Subtractive Segmentation Approach for the Exhaustive Parallel Quantification of the Extent of Protein Modification at Every Possible Site.

Authors:  Guillaume Gabant; Alain Boyer; Martine Cadene
Journal:  J Am Soc Mass Spectrom       Date:  2016-05-31       Impact factor: 3.109

2.  PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals.

Authors:  Sally E Wenzel; Yulia Y Tyurina; Jinming Zhao; Claudette M St Croix; Haider H Dar; Gaowei Mao; Vladimir A Tyurin; Tamil S Anthonymuthu; Alexandr A Kapralov; Andrew A Amoscato; Karolina Mikulska-Ruminska; Indira H Shrivastava; Elizabeth M Kenny; Qin Yang; Joel C Rosenbaum; Louis J Sparvero; David R Emlet; Xiaoyan Wen; Yoshinori Minami; Feng Qu; Simon C Watkins; Theodore R Holman; Andrew P VanDemark; John A Kellum; Ivet Bahar; Hülya Bayır; Valerian E Kagan
Journal:  Cell       Date:  2017-10-19       Impact factor: 41.582

Review 3.  A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics.

Authors:  Yuhao Wang; Benjamin Bonavida
Journal:  Crit Rev Oncog       Date:  2018

Review 4.  The role of G protein-coupled receptor kinases in the pathology of malignant tumors.

Authors:  Wu-Yi Sun; Jing-Jing Wu; Wen-Ting Peng; Jia-Chang Sun; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2018-06-19       Impact factor: 6.150

5.  Protein kinase C-mediated phosphorylation of RKIP regulates inhibition of Na-alanine cotransport by leukotriene D(4) in intestinal epithelial cells.

Authors:  Subha Arthur; Uma Sundaram
Journal:  Am J Physiol Cell Physiol       Date:  2014-09-17       Impact factor: 4.249

Review 6.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

7.  Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma.

Authors:  Hong Wei; Zhijun Liu; Hongyan She; Baoguo Liu; Junxia Gu; Dongmin Wei; Xiangyang Zhang; Jiufeng Wang; Shujing Qi; Fumin Ping
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

8.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

9.  Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway.

Authors:  Bin Li; Baolan Sun; Jianwei Zhu; Nina Zhou; Zhiping Yang; Jianhui Gu
Journal:  Tumour Biol       Date:  2014-10

Review 10.  Metastasis suppressors: functional pathways.

Authors:  Imran Khan; Patricia S Steeg
Journal:  Lab Invest       Date:  2017-10-02       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.